Sleep-Disordered Breathing and Chronic Opioid Therapy

doi:10.1111/j.1526-4637.2007.00343.x

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Pain Medicine

Volume 9 Issue 4, Pages 425 - 432

Published Online: 30 Jul 2007

Published on behalf of

Go to Society Site

< Previous Abstract | Next Abstract >

Save Article to My Profile Download Citation Request Permissions

Abstract | References | Full Text: HTML, PDF (Size: 94K) | Related Articles | Citation Tracking

OPIOIDS, SUBSTANCE ABUSE & ADDICTION SECTION

Original Research Articles

Sleep-Disordered Breathing and Chronic Opioid Therapy

Lynn R. Webster, MD,* Youngmi Choi, MD, PhD, ^† Himanshu Desai, MD, ^†‡ Linda Webster, RPSGT, ^§ and Brydon J. B. Grant, MD ^†‡¶

*Lifetree Clinical Research and Pain Clinic, Salt Lake City, Utah, USA; ^† Departments of Medicine, ^‡ Physiology and Biophysics, Social and Preventive Medicine and Biostatistics, University at Buffalo SUNY, ^§ Medical One Medical, Sandy, Utah USA; and ^¶ Veteran Affairs Healthcare System, Buffalo, New York, USA

Correspondence to Lynn R. Webster, MD, 3838 South, 700 East, Suite 200, Salt Lake City, Utah 84106, USA. Tel: 801-261-4988; Fax: 801-269-9427; E-mail: lynnw@lifetreepain.com.

KEYWORDS

Obstructive Sleep Apnea • Central Sleep Apnea • Complex Sleep Apnea • Ehronie Nonmalignant Pain • Opioids • Methadone

ABSTRACT

Objective. To assess the relation between medications prescribed for chronic pain and sleep apnea.

Design. An observational study of chronic pain patients on opioid therapy who received overnight polysomnographies. Generalized linear models determined whether a dose relation exists between methadone, nonmethadone opioids, and benzodiazepines and the indices measuring sleep apnea.

Setting. A private clinic specializing in the treatment of chronic pain.

Patients. Polysomnography was sought for all consecutive (392) patients on around-the-clock opioid therapy for at least 6 months with a stable dose for at least 4 weeks. Of these, 147 polysomnographies were completed (189 patients declined, 56 were directed to other sleep laboratories by insurance companies, and data were incomplete for seven patients). Available data were analyzed on 140 patients.

Outcome Measures. The apnea–hypopnea index to assess overall severity of sleep apnea and the central apnea index to assess central sleep apnea.

Results. The apnea–hypopnea index was abnormal (≥5 per hour) in 75% of patients (39% had obstructive sleep apnea, 4% had sleep apnea of indeterminate type, 24% had central sleep apnea, and 8% had both central and obstructive sleep apnea); 25% had no sleep apnea. We found a direct relation between the apnea–hypopnea index and the daily dosage of methadone (P = 0.002) but not to other around-the-clock opioids. We found a direct relation between the central apnea index and the daily dosage of methadone (P = 0.008) and also with benzodiazepines (P = 0.004).

Conclusions. Sleep-disordered breathing was common in chronic pain patients on opioids. The dose–response relation of sleep apnea to methadone and benzodiazepines calls for increased vigilance.

DIGITAL OBJECT IDENTIFIER (DOI)

10.1111/j.1526-4637.2007.00343.x About DOI